Focus box
New SARS-CoV-2 variants push Covid-19 vaccine long-term durability questions to back seat
Long-term Covid-19 vaccine durability has become less of an endgame since it has become increasingly likely additional shots will be…
Trial resumptions slowing due to new Covid-19 strains
Since early March 2020, more than 500 companies have publicly announced disruptions to their planned and ongoing clinical trials due…
Johnson & Johnson’s single-shot Covid-19 vaccine best used to control outbreak, while Novavax’s vaccine shows better overall protection
With Johnson & Johnson (J&J) and Novavax, two more companies presented Covid-19 vaccine efficacy data last week. With an efficacy…
Covid-19 may result in brain damage and increase the risk of dementia
There are now more than 95 million confirmed cases of Covid-19 worldwide. The disease has reached 193 countries, with the…
Regeneron reports positive interim data from Covid-19 trial
Regeneron Pharmaceuticals has reported positive initial results from an ongoing Phase III clinical trial of antibody cocktail REGEN-COV used as…